Latest Tax Incentives News

Percheron Therapeutics has terminated its phase IIb avicursen trial for Duchenne muscular dystrophy after failing to meet efficacy endpoints, while securing $14.85 million in fresh capital to explore new therapeutic opportunities.

Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.

Everest Metals Corporation is issuing $720,000 in Junior Minerals Exploration Incentive credits to shareholders from its recent $2.4 million capital raising, offering a 30% effective tax credit on investments made during FY24.

Neurotech International has secured a $2.44 million R&D tax incentive refund, strengthening its cash position as it advances clinical trials for paediatric neurological disorders and prepares for regulatory submissions in FY2025.

Premier1 Lithium's latest quarterly report reveals multiple high-grade gold assay results at its Yalgoo Project and a successful $1.5 million capital raise, setting the stage for imminent drilling activities.

West Cobar Metals reports significant resource expansions at its Salazar project alongside promising copper-antimony test results at Bulla Park, while aggressively trimming costs to extend its runway.

Magnum Mining and Exploration Limited reported a net cash outflow of $87.68k for Q4 2024, ending the quarter with $332.81k in cash and a substantial $11 million in unused financing facilities.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.

Impact Minerals reports a maiden Measured Resource at its Lake Hope High Purity Alumina Project and secures $2.87 million in government funding to accelerate pilot plant development, while progressing exploration and IPO plans for other assets.

Bluechiip Limited reported a $221,000 net cash outflow for Q2 FY2025, with cash reserves dwindling to $121,000. The company has initiated a strategic review and plans a capital raise to secure its future.

Bluechiip Limited advances its strategic repositioning with a new licensing agreement valued up to USD 750,000 alongside ongoing efforts to lift its trading suspension and grow sales.